BioSpace News Archive

Culturelle®, the leading probiotic brand, and Persona™ Nutrition, the top personalized vitamin program, today announced a partnership to deliver Culturelle probiotic through Persona’s personalized nutrition program. Culturelle will be paired with Persona’s Foundational™ Multi to optimize overall health.

The Missouri Mesothelioma Victims Center is urging a power plant or public utility worker with mesothelioma or asbestos exposure lung cancer anywhere in Missouri or their family members to call them anytime at 800-714-0303 for direct access to one of the nation’s most skilled and experienced mesothelioma attorneys - Erik Karst, founding partner of Karst von Oiste.

The Mesothelioma Compensation Center is the top ranked source in the nation for the best possible financial compensation results for a Navy Veteran with mesothelioma or asbestos exposure lung cancer because of exposure to asbestos on a nuclear submarine

Colder months may be the perfect opportunity to rest and recover while allowing results of procedures to be fully evident in time for warmer weather.

These events help survivors cope with the tragedy of losing someone to suicide.

Adding Decades of Leadership Experience in Personalized Medicine, Digital Health and Life Sciences

- Omron HeartGuide®, the first wearable blood pressure device, will integrate with physIQ’s pinpointIQ® analytics platform to indicate a potential health risk - This combined solution is being deployed to help manage recently-discharged, at-risk patients - The goal is to provide clinicians with physiological insight to proactively address potential clinical deterioration

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, highlighted positive Phase 2/3 clinical trial data from arimoclomol licensee Orphazyme A/S (CPH: ORPHA).

Ambra Health, makers of the leading cloud-based, medical image management suite, today announced that Naugatuck Valley Radiology and Insight Imaging are among the latest groups of leading providers and networks to adopt Ambra’s digital health solutions for Cloud VNA.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) this week marks its third anniversary with the announcement that more than 3,500 people with amyotrophic lateral sclerosis (ALS) have been treated with RADICAVA® (edaravone) in the U.S.